Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Barbados Today
barbadostoday.bb > 09/11/2026 > microbe-patents-could-unlock-billions-export-barbados

Microbe patents???could unlock billions??? - Export Barbados

2+ day, 9+ hour ago   (614+ words) The government’s move to patent a group of microbes discovered by UWI Cave Hill science researcher Dr Bidyut Mohapatra could create multi-billion-dollar opportunities for Barbados, the country’s export promotion chief has said. The push to patent began after Dr Mohapatra…...

BioBuzz
biobuzz.io > news > five-of-marylands-15-reallist-innovators-for-2026-have-ties-to-life-sciences-and-healthcare

Five of Maryland's 15 RealLIST Innovators for 2026 Have Ties to Life Sciences and Healthcare

3+ day, 7+ hour ago   (22+ words) BioBuzz Help us improve your BioBuzz experience....

Google News
bioworld.com > articles > 733990-mighty-therapeutics-begins-ind-enabling-studies-of-mytx-255

Mighty Therapeutics begins IND-enabling studies of MYTX-255 | BioWorld

3+ day, 19+ hour ago   (16+ words) Mighty Therapeutics begins IND-enabling studies of MYTX-255 BioWorld News Mighty Therapeutics begins IND-enabling studies of MYTX-255...

@law360
law360.com > articles > 2523793 > frazier-life-sciences-adds-1-1b-to-its-public-fund

Frazier Life Sciences Adds $1.1B To Its Public Fund

3+ day, 13+ hour ago   (58+ words) Law360 Try our Advanced Search for more refined results The Practice of Law Deep News & Analysis Law360 | The Practice of Law Law360 Authority | Deep News & Analysis Law360 Pulse | The Business of Law Frazier Life Sciences Adds $1.1B To Its Public Fund Law360 is on it, so…...

BioSpace
biospace.com > business > takedas-long-term-r-d-head-announces-exit-after-major-pipeline-reorganization

Takeda’s long-term R&D head announces exit after major pipeline reorganization

3+ day, 10+ hour ago   (499+ words) iStock, Agdekon Media Visuals Takeda’s R&D chief Andy Plump will say good-bye to the drugmaker, with a retirement slated for next summer. “Andy has made the personal decision to retire in June 2027 after more than 10 years leading Takeda’s global…...

Endpoints News
endpoints.news > how-past-endpoints-11-winners-fared-as-biotech-industry-rebounded

How past Endpoints 11 winners fared as the biotech industry rebounded

3+ day, 18+ hour ago   (64+ words) Endpoints News How past End­points 11 win­ners fared as the biotech in­dus­try re­bound­ed We’ll be un­veil­ing this year’s End­points 11 in Boston on the night of Sept. 24. Join us. Think we're worth reading…...

Investing.com
investing.com > news > transcripts > arcus-biosciences-at-cantor-global-healthcare-conference-casdatifan-in-focus-93CH-4896316

Arcus Biosciences at cantor global healthcare conference: casdatifan in focus By Investing.com

3+ day, 17+ hour ago   (1701+ words) U.S. stocks fall at the open, bonds slide after August producer inflation report Piper Sandler lists 5 chip stocks to buy Oracle reports earnings today: AI spending bet faces its toughest test yet Trump on Iran war; Oracle, Adobe to report - what’s…...

tovima.com
tovima.com > politics > mitsotakis-touts-e1bn-pharma-push-at-athens-biotech-hub

Mitsotakis Touts???1bn Pharma Push at Athens Biotech Hub

3+ day, 21+ hour ago   (235+ words) Eurogroup President Kyriakos Pierrakakis calls for AI, technology and digital finance to become central pillars of the Eurozone's economic agenda. Mitsotakis argued that the new park’s significance extends well beyond its role as a hub for preclinical research and start-up…...

BioPharma Dive
biopharmadive.com > news > biotech-reverse-mergers-public-markets-ipo > 829197

A booming business on Wall Street would love more biotechs to quietly die

3+ day, 20+ hour ago   (1705+ words) Once disparaged, reverse mergers have become so popular that some deal experts question whether there are enough quality shell companies to meet the demand. In the law firms and investment banks that broker some of the world’s biggest biotechnology deals,…...

BioXconomy
bioxconomy.com > partnering > ife-sciences-deals-surge-to-196bn-with-early-stage-asset-demand

Life Sciences M&A Hits Record High in 2026

3+ day, 23+ hour ago   (568+ words) Life sciences dealmaking hits record highs as biopharma bets big on early-stage assets amid geopolitical uncertainty. The first half of 2026 has delivered the strongest run of life sciences dealmaking on record, according to a report published by EY - a long-term…...